封面
市場調查報告書
商品編碼
2051114

核子醫學掃描術診斷設備市場:按產品類型、應用、最終用戶和地區分類

Nuclear Imaging Equipment Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2026年,核子醫學掃描術診斷設備市場規模將達37.6億美元,2033年將達54億美元。預計從2026年到2033年,該市場將以5.3%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 37.6億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 5.30% 2033年市場規模預測: 54億美元

核子醫學是醫學影像學的一個分支,它利用少量放射性物質來診斷和治療多種疾病,包括各種癌症、心臟病以及其他特定的身體異常。核子醫學掃描術診斷透過觀察器官、組織或骨骼的功能來確定病因。這與X光、超音波或其他基於結構外觀來判斷是否存在疾病的診斷測試不同。核子醫學,或稱放射性同位素成像,是一種非侵入性且通常無痛的醫學檢查,可以幫助醫生診斷疾病。這些影像檢查使用稱為放射性藥物或放射性追蹤劑的放射性物質。根據所進行的核子醫學檢查類型,放射性追蹤劑可以透過靜脈注射、口服或吸入氣體的方式給藥,最終積聚在被檢查的器官或身體部位,並以伽馬射線的形式釋放能量。這種能量由稱為伽馬攝影機、正子斷層掃描(PET)掃描儀和/或探針的設備進行檢測。

市場動態

預計全球各種癌症發生率的不斷上升將推動預測期內市場成長。此外,市場參與者活性化研發投入以及推出新產品也將促進預測期內市場成長。例如,根據美國癌症協會2022年2月4日發布的數據,2021年全球估計新增癌症病例1930萬例,癌症相關死亡病例1000萬例。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
      • 癌症和心臟病發生率增加
      • 診斷成像技術進步。
    • 抑制因子
      • 核子醫學掃描術診斷設備高成本
    • 機會
      • 混合影像診斷
    • 主要亮點
    • 監管趨勢
    • 近期趨勢
    • 產品上市及核准
    • PEST分析
    • 波特的分析
    • 併購和合作

第4章:核子醫學掃描術診斷設備市場:依產品類型分類,2021-2033年

  • 單光子發射電腦斷層掃描(SPECT)
  • 正子斷層掃描(PET)
  • 混合PET-CT
  • 混合SPECT-CT
  • 混合PET-MRI
  • 其他

第5章:核子醫學掃描術診斷設備市場:依應用領域分類,2021-2033年

  • 腫瘤學
  • 循環系統
  • 神經病學
  • 其他

第6章:核子醫學掃描術診斷設備市場:依最終用戶分類,2021-2033年

  • 醫院和診所
  • 診斷影像中心
  • 研究機構
  • 其他

第7章核子醫學掃描術診斷設備市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • ASEAN
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • 公司簡介
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Canon Medical Systems
    • Mediso Medical Imaging Systems
    • MIE America
    • DDD Diagnostic
    • Segami
    • Digirad

第9章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI2366

Nuclear Imaging Equipment Market is estimated to be valued at USD 3.76 Bn in 2026 and is expected to reach USD 5.40 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.30% 2033 Value Projection: USD 5.40 Bn

Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose or treat a variety of diseases, including many types of cancers, heart disease and certain other abnormalities within the body. Nuclear imaging determines the cause of the medical problem based on the function of the organ, tissue or bone. This is how nuclear imaging differs from an X-ray, ultrasound or any other diagnostic test that determines the presence of disease based on structural appearance. Nuclear medicine or radionuclide imaging procedures are noninvasive and usually painless medical tests that help physicians diagnose medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. Depending on the type of nuclear medicine exam are done, the radiotracer is either injected into a vein, swallowed or inhaled as a gas and eventually accumulates in the organ or area of your body being examined, where it gives off energy in the form of gamma rays. This energy is detected by a device called a gamma camera, a (positron emission tomography) PET scanner and/or probe.

Market Dynamics

Increasing prevalence of various cancers globally is expected to propel the market growth over the forecast period. Moreover, increasing research and development (R&D) and increasing product launches by the market players will aid in the market growth over the forecast period. For instance, according to the data published by the American Cancer Society on February 4, 2022, worldwide, an estimated 19.3 Mn new cancer cases and 10 Mn cancer deaths occurred in 2021.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Single Photon Emission Computed Tomography (SPECT)
  • Positron Emission Tomography (PET)
  • Hybrid PET-CT
  • Hybrid SPECT-CT
  • Hybrid PET-MRI
  • Others
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Oncology
  • Cardiology
  • Neurology
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals and clinics
  • Diagnostic imaging centers
  • Research institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems
  • Mediso Medical Imaging Systems
  • MIE America
  • DDD Diagnostic
  • Segami
  • Digirad

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
      • Increasing incidence of cancer & cardiac disease
      • Technological advancements in imaging modalities
    • Restraint
      • High cost of nuclear imaging modalities
    • Opportunity
      • Hybrid imaging modalities
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Mergers, Acquisitions, and Collaborations

4. Nuclear Imaging Equipment Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single Photon Emission Computed Tomography (SPECT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Positron Emission Tomography (PET)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hybrid PET-CT
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hybrid SPECT-CT
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hybrid PET-MRI
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Nuclear Imaging Equipment Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Nuclear Imaging Equipment Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals and clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic imaging centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Nuclear Imaging Equipment Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • Japan
      • India
      • Australia
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Company Profile
    • GE Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Siemens Healthineers
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Philips Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Canon Medical Systems
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mediso Medical Imaging Systems
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • MIE America
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • DDD Diagnostic
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Segami
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Digirad
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us